Regional: Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project
This proposed Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project (the project) will form part of the regional response to reduce the number of cervical cancer cases and other infectious diseases in children and women. The project proposes to use the introduction of new vaccines and early detection through communicable disease platforms to drive necessary improvements in the public health system in selected Pacific DMCs in line with the Asia Pacific Strategy for Emerging Diseases and Public Health Emergency.
Project Details
-
Project Officer
Mikkelsen-Lopez, Inez
Pacific Department
Request for information -
Country/Economy
Regional -
Sector
- Health
Related Projects
| Project Name | Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project | ||||||||||||||||||||||||||||||||||||
| Project Number | 50282-001 | ||||||||||||||||||||||||||||||||||||
| Country / Economy | Regional Samoa Tonga Tuvalu Vanuatu |
||||||||||||||||||||||||||||||||||||
| Project Status | Active | ||||||||||||||||||||||||||||||||||||
| Project Type / Modality of Assistance | Grant Loan |
||||||||||||||||||||||||||||||||||||
| Source of Funding / Amount |
|
||||||||||||||||||||||||||||||||||||
| Strategic Agendas | Inclusive economic growth Regional integration |
||||||||||||||||||||||||||||||||||||
| Drivers of Change | Gender Equity and Mainstreaming Governance and capacity development Knowledge solutions Partnerships |
||||||||||||||||||||||||||||||||||||
| Sector / Subsector | Health / Disease control of communicable disease - Health system development |
||||||||||||||||||||||||||||||||||||
| Gender Equity and Mainstreaming | Gender equity | ||||||||||||||||||||||||||||||||||||
| Description | This proposed Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project (the project) will form part of the regional response to reduce the number of cervical cancer cases and other infectious diseases in children and women. The project proposes to use the introduction of new vaccines and early detection through communicable disease platforms to drive necessary improvements in the public health system in selected Pacific DMCs in line with the Asia Pacific Strategy for Emerging Diseases and Public Health Emergency. | ||||||||||||||||||||||||||||||||||||
| Project Rationale and Linkage to Country/Regional Strategy | Human papillomavirus (HPV) causes almost all cervical cancers through communicable disease transmission. Cervical cancer is a major cause of premature death in the Pacific causing nearly 500 deaths in 2010 and is therefore a leading cause of death among women in 2010 across the Pacific region. It is largely preventable through cost effective interventions of early detection and HPV vaccination. Immunization is pro-poor, providing relatively larger benefits to low-income households. | ||||||||||||||||||||||||||||||||||||
| Impact | Incidence and prevalence of cervical cancer in the Pacific region reduced; healthy lives ensured and well-being for all at all ages promoted; and SARS-Cov2 virus spread, morbidity and mortality reduced, and confidence of citizens restored. | ||||||||||||||||||||||||||||||||||||
| Project Outcome | |
|---|---|
| Description of Outcome | Immunization coverage of vaccines increased |
| Progress Toward Outcome | |
| Implementation Progress | |
| Description of Project Outputs | Regional vaccine procurement strengthened Health systems strengthened Community awareness improved |
| Status of Implementation Progress (Outputs, Activities, and Issues) | |
| Geographical Location | Samoa - Nation-wide; Tonga - Nation-wide; Tuvalu - Nation-wide; Vanuatu - Nation-wide |
| Safeguard Categories | |
|---|---|
| Environment | C |
| Involuntary Resettlement | C |
| Indigenous Peoples | C |
| Summary of Environmental and Social Aspects | |
|---|---|
| Environmental Aspects | The project will have no adverse environmental impacts. |
| Involuntary Resettlement | The project will have minimal or no adverse social impacts. |
| Indigenous Peoples | The project will have minimal or no adverse social impacts. |
| Stakeholder Communication, Participation, and Consultation | |
| During Project Design | The project will impact women and children. During project preparation, consultation and participation will include: (i) group discussions with (potential) beneficiaries, health workers, and community-based organizations; (ii) consultation of health staff and district health managers, sub-national level government administration, central ministries, and partners; and (iii) where appropriate, workshop with ministries, partners, and nongovernment organizations. |
| During Project Implementation | Project outputs include increase in awareness of vaccines in key stakeholder groups. Support will be provided to Ministries of Education and Health and nongovernment organizations/civil society to develop health promotion strategies on the importance of vaccination/screening. |
| Business Opportunities | |
|---|---|
| Consulting Services | All consultants will be recruited according to ADB's Guidelines on the Use of Consultants. |
| Procurement | Any procurement of equipment or consulting services will conform with ADB's Procurement Guidelines. |
| Responsible ADB Officer | Mikkelsen-Lopez, Inez |
| Responsible ADB Department | Pacific Department |
| Responsible ADB Division | PASP |
| Executing Agencies |
Ministry of Finance [email protected] Ministry of Finance Government of Samoa Private Bag, Apia, Samoa Ministry of Finance Ministry of Finance Government of Samoa Private Bag, Apia, Samoa Ministry of Finance Vaiaku, Funafuti, Tuvalu Ministry of Finance Vuna Road Nuku'alofa Kingdom of Tonga Ministry of Finance & Economic Management P.M.B. 058 Port Vila Vanuatu Ministry of Finance, Commerce, Trade & Tourism P.O. Box 381 Constitution Bldg., Kumul Highway Port Vila, Republic of Vanuatu |
| Timetable | |
|---|---|
| Concept Clearance | 10 Jan 2017 |
| Fact Finding | 10 Apr 2018 to 19 Apr 2018 |
| MRM | 09 Aug 2018 |
| Approval | 08 Nov 2018 |
| Last Review Mission | - |
| Last PDS Update | 08 Nov 2018 |
Grant 0623-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 08 Nov 2018 | 21 Jan 2019 | 01 Jul 2019 | 31 May 2024 | 31 May 2026 | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 12.06 | Cumulative Contract Awards | |||
| ADB | 7.50 | 01 Apr 2022 | 4.41 | 0.00 | 59% |
| Counterpart | 4.56 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 01 Apr 2022 | 3.22 | 0.00 | 43% |
| Status of Covenants | ||||||
|---|---|---|---|---|---|---|
| Category | Sector | Safeguards | Social | Financial | Economic | Others |
| Rating | - | Satisfactory | - | - | - | Satisfactory |
Grant 0624-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 08 Nov 2018 | 29 Nov 2018 | 14 Aug 2019 | 31 May 2024 | 31 May 2026 | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 3.85 | Cumulative Contract Awards | |||
| ADB | 3.85 | 01 Apr 2022 | 2.62 | 0.00 | 68% |
| Counterpart | 0.00 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 01 Apr 2022 | 1.99 | 0.00 | 52% |
| Status of Covenants | ||||||
|---|---|---|---|---|---|---|
| Category | Sector | Safeguards | Social | Financial | Economic | Others |
| Rating | - | Satisfactory | - | - | - | Satisfactory |
Grant 0625-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 08 Nov 2018 | 12 Dec 2018 | 29 Aug 2019 | 31 May 2024 | 31 May 2026 | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 2.50 | Cumulative Contract Awards | |||
| ADB | 2.50 | 01 Apr 2022 | 1.85 | 0.00 | 74% |
| Counterpart | 0.00 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 01 Apr 2022 | 1.07 | 0.00 | 43% |
| Status of Covenants | ||||||
|---|---|---|---|---|---|---|
| Category | Sector | Safeguards | Social | Financial | Economic | Others |
| Rating | - | Satisfactory | - | - | - | Satisfactory |
Grant 0626-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 08 Nov 2018 | 28 Feb 2019 | 01 Jul 2019 | 31 May 2024 | 31 May 2026 | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 9.00 | Cumulative Contract Awards | |||
| ADB | 9.00 | 01 Apr 2022 | 5.11 | 0.00 | 57% |
| Counterpart | 0.00 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 01 Apr 2022 | 3.45 | 0.00 | 38% |
| Status of Covenants | ||||||
|---|---|---|---|---|---|---|
| Category | Sector | Safeguards | Social | Financial | Economic | Others |
| Rating | - | Satisfactory | - | - | - | Satisfactory |
Grant 0787-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 23 Apr 2021 | 19 May 2021 | 09 Jun 2021 | 31 May 2024 | 31 May 2026 | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 1.57 | Cumulative Contract Awards | |||
| ADB | 1.50 | 01 Apr 2022 | 1.12 | 0.00 | 74% |
| Counterpart | 0.07 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 01 Apr 2022 | 0.91 | 0.00 | 60% |
| Status of Covenants | ||||||
|---|---|---|---|---|---|---|
| Category | Sector | Safeguards | Social | Financial | Economic | Others |
| Rating | - | Satisfactory | - | - | - | Satisfactory |
Grant 0788-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 23 Apr 2021 | 31 May 2021 | 18 Jun 2021 | 31 May 2024 | 31 May 2026 | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 8.40 | Cumulative Contract Awards | |||
| ADB | 8.00 | 01 Apr 2022 | 0.00 | 0.00 | 0% |
| Counterpart | 0.40 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 01 Apr 2022 | 0.00 | 0.00 | 0% |
| Status of Covenants | ||||||
|---|---|---|---|---|---|---|
| Category | Sector | Safeguards | Social | Financial | Economic | Others |
| Rating | - | Satisfactory | - | - | - | Satisfactory |
Grant 0789-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 23 Apr 2021 | 20 May 2021 | 10 Jun 2021 | 31 May 2024 | 31 May 2026 | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 5.77 | Cumulative Contract Awards | |||
| ADB | 5.50 | 01 Apr 2022 | 4.64 | 0.00 | 84% |
| Counterpart | 0.27 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 01 Apr 2022 | 3.90 | 0.00 | 71% |
| Status of Covenants | ||||||
|---|---|---|---|---|---|---|
| Category | Sector | Safeguards | Social | Financial | Economic | Others |
| Rating | - | Satisfactory | - | - | - | Satisfactory |
Grant 0790-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 23 Apr 2021 | 07 Jun 2021 | 18 Jun 2021 | 31 May 2024 | 31 May 2026 | - |
| Financing Plan | Grant Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 4.08 | Cumulative Contract Awards | |||
| ADB | 3.88 | 01 Apr 2022 | 3.49 | 0.00 | 90% |
| Counterpart | 0.20 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 01 Apr 2022 | 3.13 | 0.00 | 81% |
| Status of Covenants | ||||||
|---|---|---|---|---|---|---|
| Category | Sector | Safeguards | Social | Financial | Economic | Others |
| Rating | - | Satisfactory | - | - | - | Satisfactory |
Loan 3736-REG
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 08 Nov 2018 | 28 Feb 2019 | 01 Jul 2019 | 31 May 2024 | 31 May 2026 | - |
| Financing Plan | Loan Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 2.25 | Cumulative Contract Awards | |||
| ADB | 2.25 | 01 Apr 2022 | 1.67 | 0.00 | 74% |
| Counterpart | 0.00 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 01 Apr 2022 | 1.67 | 0.00 | 74% |
| Status of Covenants | ||||||
|---|---|---|---|---|---|---|
| Category | Sector | Safeguards | Social | Financial | Economic | Others |
| Rating | - | Satisfactory | - | - | - | Satisfactory |
Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.
The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.
The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.
In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.
Safeguard Documents See also: Safeguards
Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.
None currently available.
Evaluation Documents See also: Independent Evaluation
None currently available.
Related Publications
None currently available.
The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.
Requests for information may also be directed to the InfoUnit.
-
ADB, UNICEF Support Rollout of Vaccines for Children in Samoa, Tonga, Tuvalu Against Infectious Diseases, Cervical Cancer
The rollout of vaccines to protect children against cervical cancer, pneumonia, and rotavirus has begun in Samoa, Tonga, and Tuvalu. -
Vaccinating in Vanuatu for a Healthier Future
A $15 million grant from an Asian Development Fund (ADF) 12 facility will reduce the burden of pneumonia and diarrhea in children and increase protection against the human papilloma virus in women. -
UNICEF Signs Agreement to Support Immunization in Samoa Under ADB-Financed Project
UNICEF and Samoa have signed a grant agreement to provide support to the health sector to strengthen the country’s immunization program and procure cold chain equipment to safely transport vaccines, which is supported by ADB... -
ADB Signs Loan and Grant Agreements to Introduce New Vaccines in Vanuatu
ADB and Vanuatu today signed agreements for a grant and a loan to fund the introduction of new vaccines in Vanuatu through the ADB-supported System Strengthening for Effective Coverage of New Vaccines in the Pacific Project. -
ADB Assistance to Help Prevent Cervical Cancer, Other Infectious Diseases in Pacific
ADB's Board of Directors has approved a total financing package of $29.7 million to support the introduction of new vaccines in Samoa, Tonga, Tuvalu, and Vanuatu.
Tenders
| Tender Title | Type | Status | Posting Date | Deadline |
|---|---|---|---|---|
| Integrated Project Management | Firm - Consulting | Closed | 26 Feb 2019 | 17 Apr 2019 |
Contracts Awarded
| Contract Title | Approval Number | Contract Date | Contractor | Address | Executing Agency | Total Contract Amount (US$) | Contract Amount Financed by ADB (US$) |
|---|---|---|---|---|---|---|
| INTEGRATED PROJECT MANAGEMENT CONSULTANT FOR THE PROJECT - SAM | Grant 0623 | 08 Jul 2020 | ABT ASSOCIATES PTY. LTD (ACN 091 591 294) | LEVEL 2 5 GARDENER CLOSE MILTON QUEENSLAND 4068 AUSTRALIA | Ministry of Finance | 1,500,000.00 | — |
| UNICEF VII AGREEMENT WITH SAMOA | Grant 0623 | 24 Apr 2020 | UNITED NNATIONS CHILDREN'S FUND (UNICEF) | FDB BUILDING 360 VICTORIA PARADE SUVA FIJI FIJI REPUBLIC OF | Ministry of Finance | 603,000.00 | — |
Procurement Plan
| Title | Document Type | Document Date |
|---|---|---|
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project: Samoa Procurement Plan | Procurement Plans | Aug 2021 |
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project: Tonga Procurement Plan | Procurement Plans | Aug 2021 |
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project: Vanuatu Procurement Plan | Procurement Plans | Aug 2021 |
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project: Tuvalu Procurement Plan | Procurement Plans | Aug 2021 |
| Systems Strengthening for Effective Coverage of New Vaccines in the Pacific Project: Procurement Plan | Procurement Plans | Jul 2018 |